All In MedTech

Device Trial Radar · NCT06722755

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation

Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Jan 15, 2025

Primary completion

Apr 2028

Study completion May 2028

Sponsor

Lead sponsor
University of WashingtonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Dec 9, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR). The study is a multicenter randomized controlled trial (RCT) involving recruitment of about 250 participants across two institutions and randomization of about 200 participants. It compares an intensive support (IS) program for CPAP use with standard support (SS) to evaluate the effectiveness of the IS intervention in increasing CPAP usage during and after stroke rehabilitation. The Intensive Support (IS) group will receive a multicomponent intensive behavioral adherence program, which includes a CPAP technical support intervention, Motivational Enhancement Therapy (MET), and a Mobile Health intervention. Outcomes measured include CPAP adherence as measured by average nightly use in minutes between randomization and 3 months and the modified Rankin Scale (mRS-9Q) to evaluate stroke recovery.

Conditions

  • Stroke Patients
  • CPAP
  • OSA - Obstructive Sleep Apnea

Interventions

  • CPAP deviceDevice

    Eligible participants with OSA will be started on automatically-adjusting CPAP.

  • CPAP technical supportBehavioral

    Trained personnel will conduct mask selection and fitting, provide continual troubleshooting, and train participants on CPAP.

  • Phone follow-up for adherence feedback and self-management skillsBehavioral

    The research coordinator will call participants approximately monthly to provide any needed support.

  • myAirBehavioral

    Study personnel will assist participants in registering for and using the myAir (ResMed) self-tracking app. This app also provides a library of how-to videos and provides email updates to participants.

  • Tailored messagesBehavioral

    Tailored text messages will be sent to participants. Two-way texting messaging will also be available between the study team and participants.

  • Written MaterialsBehavioral

    A binder of written educational materials will be provided to participants.

  • Motivational Enhancement Therapy (MET)Behavioral

    A trained sleep coach will conduct up to 5 MET sessions with participants and 2 sessions with a CPAP partner during the study time period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CPAP AdherenceTime frame: 3 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Rancho Research Institute

    Downey, California · Recruiting

  • University of Washington - Harborview Medical Center

    Seattle, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.